These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 38397975)

  • 41. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement.
    Bulfamante GP; Perrucci GL; Falleni M; Sommariva E; Tosi D; Martinelli C; Songia P; Poggio P; Carugo S; Pompilio G
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33352880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nomogram to identify severe coronavirus disease 2019 (COVID-19) based on initial clinical and CT characteristics: a multi-center study.
    Yu Y; Wang X; Li M; Gu L; Xie Z; Gu W; Xu F; Bao Y; Liu R; Hu S; Hu M; Hu C
    BMC Med Imaging; 2020 Oct; 20(1):111. PubMed ID: 33008329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
    Fox SE; Li G; Akmatbekov A; Harbert JL; Lameira FS; Brown JQ; Vander Heide RS
    Circulation; 2020 Sep; 142(11):1123-1125. PubMed ID: 32689809
    [No Abstract]   [Full Text] [Related]  

  • 44. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 45. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 46. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.
    Chen R; Liang W; Jiang M; Guan W; Zhan C; Wang T; Tang C; Sang L; Liu J; Ni Z; Hu Y; Liu L; Shan H; Lei C; Peng Y; Wei L; Liu Y; Hu Y; Peng P; Wang J; Liu J; Chen Z; Li G; Zheng Z; Qiu S; Luo J; Ye C; Zhu S; Liu X; Cheng L; Ye F; Zheng J; Zhang N; Li Y; He J; Li S; Zhong N;
    Chest; 2020 Jul; 158(1):97-105. PubMed ID: 32304772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 with Different Severities: A Multicenter Study of Clinical Features.
    Feng Y; Ling Y; Bai T; Xie Y; Huang J; Li J; Xiong W; Yang D; Chen R; Lu F; Lu Y; Liu X; Chen Y; Li X; Li Y; Summah HD; Lin H; Yan J; Zhou M; Lu H; Qu J
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1380-1388. PubMed ID: 32275452
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
    Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
    JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium.
    Tan KS; Lim RL; Liu J; Ong HH; Tan VJ; Lim HF; Chung KF; Adcock IM; Chow VT; Wang Y
    Front Cell Dev Biol; 2020; 8():99. PubMed ID: 32161756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration.
    Dao DT; Anez-Bustillos L; Adam RM; Puder M; Bielenberg DR
    Am J Pathol; 2018 Nov; 188(11):2446-2456. PubMed ID: 30142332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
    Venkataraman T; Coleman CM; Frieman MB
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways.
    Taylor SR; Markesbery MG; Harding PA
    Semin Cell Dev Biol; 2014 Apr; 28():22-30. PubMed ID: 24680771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway.
    Lian H; Ma Y; Feng J; Dong W; Yang Q; Lu D; Zhang L
    PLoS One; 2012; 7(9):e44946. PubMed ID: 22984591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.
    Svensson KJ; Kucharzewska P; Christianson HC; Sköld S; Löfstedt T; Johansson MC; Mörgelin M; Bengzon J; Ruf W; Belting M
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13147-52. PubMed ID: 21788507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA
    Biochim Biophys Acta; 2007 Aug; 1773(8):1263-84. PubMed ID: 17126425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes.
    Ushikoshi H; Takahashi T; Chen X; Khai NC; Esaki M; Goto K; Takemura G; Maruyama R; Minatoguchi S; Fujiwara T; Nagano S; Yuge K; Kawai T; Murofushi Y; Fujiwara H; Kosai K
    Lab Invest; 2005 Jul; 85(7):862-73. PubMed ID: 15856048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
    Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.
    Fang L; Li G; Liu G; Lee SW; Aaronson SA
    EMBO J; 2001 Apr; 20(8):1931-9. PubMed ID: 11296226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
    Marikovsky M; Breuing K; Liu PY; Eriksson E; Higashiyama S; Farber P; Abraham J; Klagsbrun M
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3889-93. PubMed ID: 8483908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein.
    Higashiyama S; Lau K; Besner GE; Abraham JA; Klagsbrun M
    J Biol Chem; 1992 Mar; 267(9):6205-12. PubMed ID: 1556128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.